Filters: Keyword is Drug Administration Schedule [Clear All Filters]
"Treatment of heroin dependence with buprenorphine in primary care." The American journal of drug and alcohol abuse 28, no. 2 (2002): 231-41. Abstract
"Adherence to antiretroviral therapy among patients with HIV: a critical link between behavioral and biomedical sciences." Journal of acquired immune deficiency syndromes (1999) 31 Suppl 3 (2002): S98-102. Abstract
"Report on the XIV International AIDS Conference." AIDS clinical care 14, no. 9 (2002): 77-85.
"A preliminary, controlled investigation of magnesium L-aspartate hydrochloride for illicit cocaine and opiate use in methadone-maintained patients." Journal of addictive diseases 22, no. 2 (2003): 49-61. Abstract
"Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction." AIDS (London, England) 19, no. 15 (2005): 1635-41. Abstract
"HIV medication adherence. The intersection of biomedical, behavioral, and social science research and clinical practice." Journal of acquired immune deficiency syndromes (1999) 43 Suppl 1 (2006): S3-9. Abstract
"Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S224-34. Abstract
"Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S235-46. Abstract
"Opioid dependence: rationale for and efficacy of existing and new treatments." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S173-7. Abstract
"The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S178-83. Abstract
"A trial of integrated buprenorphine/naloxone and HIV clinical care." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S184-90. Abstract
"Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies." AIDS (London, England) 21, no. 12 (2007): 1579-89. Abstract
"Report from the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Further exploring the findings from SMART." AIDS clinical care 19, no. 10 (2007): 83.
"A randomized comparison of two instruments for measuring self-reported antiretroviral adherence." AIDS care 20, no. 2 (2008): 161-9. Abstract
"The impact of episodic CD4 cell count-guided antiretroviral therapy on quality of life." Journal of acquired immune deficiency syndromes (1999) 47, no. 2 (2008): 185-93. Abstract
"Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model." Annals of internal medicine 148, no. 3 (2008): 178-85. Abstract
"Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 17, no. 2 (2008): 116-20. Abstract
"Report from the 16th Conference on Retroviruses and Opportunistic Infections. When should ART be initiated in patients with OIs?" Journal watch. AIDS clinical care 21, no. 4 (2009): 31-2.
"Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies." Lancet 373, no. 9672 (2009): 1352-63. Abstract
"Effect of early versus deferred antiretroviral therapy for HIV on survival." The New England journal of medicine 360, no. 18 (2009): 1815-26. Abstract
"When to start antiretroviral therapy in resource-limited settings." Annals of internal medicine 151, no. 3 (2009): 157-66. Abstract
"Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients." AIDS (London, England) 23, no. 3 (2009): 369-75. Abstract
"Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression." Journal of acquired immune deficiency syndromes (1999) 52, no. 3 (2009): 357-63. Abstract
"Timing of initiation of antiretroviral drugs during tuberculosis therapy." The New England journal of medicine 362, no. 8 (2010): 697-706. Abstract
"The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals." AIDS (London, England) 24, no. 1 (2010): 123-37. Abstract
"Retention of functional DC-NK cross-talk following up to 18 weeks therapy interruptions in chronically suppressed HIV type 1+ subjects." AIDS research and human retroviruses 26, no. 10 (2010): 1047-9.
"When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study." Annals of internal medicine 154, no. 8 (2011): 509-15. Abstract
"Medication persistence in the treatment of HIV infection: a review of the literature and implications for future clinical care and research." AIDS (London, England) 25, no. 3 (2011): 279-90. Abstract
"Brief behavioral self-regulation counseling for HIV treatment adherence delivered by cell phone: an initial test of concept trial." AIDS patient care and STDs 25, no. 5 (2011): 303-10. Abstract
"Integration of antiretroviral therapy with tuberculosis treatment." The New England journal of medicine 365, no. 16 (2011): 1492-501. Abstract
"Counseling and directly observed medication for primary care buprenorphine maintenance: a pilot study." Journal of addiction medicine 6, no. 3 (2012): 205-11. Abstract
"Receipt of opioid analgesics by HIV-infected and uninfected patients." Journal of general internal medicine 28, no. 1 (2013): 82-90. Abstract
"Cost-effectiveness of HIV treatment as prevention in serodiscordant couples." The New England journal of medicine 369, no. 18 (2013): 1715-25. Abstract
"Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine." PloS one 9, no. 8 (2014): e103200. Abstract
